Advancements in Cancer Immunotherapies
- PMID: 36679904
- PMCID: PMC9861770
- DOI: 10.3390/vaccines11010059
Advancements in Cancer Immunotherapies
Abstract
Recent work has suggested involvement of the immune system in biological therapies specifically targeting tumor microenvironment. Substantial advancement in the treatment of malignant tumors utilizing immune cells, most importantly T cells that play a key role in cell-mediated immunity, have led to success in clinical trials. Therefore, this article focuses on the therapeutic approaches and developmental strategies to treat cancer. This review emphasizes the immunomodulatory response, the involvement of key tumor-infiltrating cells, the mechanistic aspects, and prognostic biomarkers. We also cover recent advancements in therapeutic strategies.
Keywords: CAR T cell therapy; cancer vaccines; checkpoint-inhibitors; combination therapy; tumor microenvironment; tumor-infiltrating lymphocytes.
Conflict of interest statement
The authors do not have any possible conflict of interest.
Figures



Similar articles
-
Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies.Front Immunol. 2021 Nov 18;12:777073. doi: 10.3389/fimmu.2021.777073. eCollection 2021. Front Immunol. 2021. PMID: 34868044 Free PMC article. Review.
-
Expression of costimulatory and inhibitory receptors in FoxP3+ regulatory T cells within the tumor microenvironment: Implications for combination immunotherapy approaches.Adv Cancer Res. 2019;144:193-261. doi: 10.1016/bs.acr.2019.05.001. Epub 2019 Jun 6. Adv Cancer Res. 2019. PMID: 31349899 Review.
-
Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.Adv Exp Med Biol. 2023;1394:73-84. doi: 10.1007/978-3-031-14732-6_5. Adv Exp Med Biol. 2023. PMID: 36587382
-
The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance.Cancers (Basel). 2021 Nov 29;13(23):6012. doi: 10.3390/cancers13236012. Cancers (Basel). 2021. PMID: 34885122 Free PMC article. Review.
-
Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.Pharmacotherapy. 2017 Jan;37(1):129-143. doi: 10.1002/phar.1871. Epub 2017 Jan 6. Pharmacotherapy. 2017. PMID: 27870103 Review.
Cited by
-
Recent Developments in Inertial and Centrifugal Microfluidic Systems along with the Involved Forces for Cancer Cell Separation: A Review.Sensors (Basel). 2023 Jun 2;23(11):5300. doi: 10.3390/s23115300. Sensors (Basel). 2023. PMID: 37300027 Free PMC article. Review.
-
In Situ Programming of CAR-T Cells: A Pressing Need in Modern Immunotherapy.Arch Immunol Ther Exp (Warsz). 2023 Jul 7;71(1):18. doi: 10.1007/s00005-023-00683-y. Arch Immunol Ther Exp (Warsz). 2023. PMID: 37419996 Free PMC article. Review.
-
Metabolically activated and highly polyfunctional intratumoral VISTA+ regulatory B cells are associated with tumor recurrence in early-stage NSCLC.Mol Cancer. 2025 Jan 14;24(1):16. doi: 10.1186/s12943-024-02209-2. Mol Cancer. 2025. PMID: 39810191 Free PMC article.
-
Cytoprotective effect of garlic alone versus co-administration of garlic and resveratrol in adriamycin-induced lung toxicity in albino rat: light microscopic, ultrastructural and immunohistochemical study.J Mol Histol. 2024 Oct;55(5):835-849. doi: 10.1007/s10735-024-10235-z. Epub 2024 Aug 6. J Mol Histol. 2024. PMID: 39105941
-
Parasites revive hope for cancer therapy.Eur J Med Res. 2024 Oct 5;29(1):489. doi: 10.1186/s40001-024-02057-2. Eur J Med Res. 2024. PMID: 39367471 Free PMC article. Review.
References
-
- Zeng D., Li M., Zhou R., Zhang J., Sun H., Shi M., Bin J., Liao Y., Rao J., Liao W. Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures. Cancer Immunol. Res. 2019;7:737–750. doi: 10.1158/2326-6066.CIR-18-0436. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources